Pioneering preoperative anti-PD-1 immunotherapy enables curative resection in dMMR advanced/recurrent endometrial carcinoma: a case series (2020-2022). - Fu H; Yang B; Li J; Zhu X; Yang Y; Yuan S (Discover oncology, 2026)